Crossref
Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders
The Journal of Allergy and Clinical Immunology: In Practice · 2026-07 · 14 (7) · 1504-1505
DOI: 10.1016/j.jaip.2026.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-07.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders. The Journal of Allergy and Clinical Immunology: In Practice, 14(7), 1504-1505. https://doi.org/10.1016/j.jaip.2026.06.005
Vancouver
Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(7):1504-1505. doi:10.1016/j.jaip.2026.06.005
BibTeX
@article{euvimed2026,
title = {Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {7},
pages = {1504--1505},
doi = {10.1016/j.jaip.2026.06.005}
}
EUVIMED